Site Editor

Sandy Srinivas, MD

Advertisement

Advertisement

JNCCN Spotlights

Enzalutamide (Xtandi®) Update

News

Steroid Switch in Metastatic Prostate Cancer: Outcomes of PSA Responders Versus Nonresponders

Videos

Neal D. Shore, MD, on a Possible New Standard of Care in Oral Therapy for Advanced Prostate Cancer

Medical Literature

Link Between Coffee Consumption and Risk for Prostate Cancer?

News

Relugolix Receives FDA Approval for Advanced Prostate Cancer

Medical Literature

Neoadjuvant Chemohormonal Therapy With Radical Prostatectomy for Localized Prostate Cancer

News

IL-7 After Sipuleucel-T for Advanced Prostate Cancer

Rana R. McKay, MD: Which Patients Might Benefit From Neoadjuvant Androgen Deprivation Before Radical Prostatectomy?

Daniel P. Petrylak, MD, on Understanding ARV-110, an Oral PROTAC Degrader for Prostate Cancer Treatment

View More

Advertisement

JNCCN Spotlights

Apalutamide (Erleada^™)

Docetaxel (Castration-Naive Metastatic Prostate Cancer)

Enzalutamide (Xtandi®) Update

View More

More

News

Immunochemotherapy for Metastatic Castration-Resistant Prostate Cancer: KEYNOTE-365 Cohort B Update

Novel Immunotherapy Combination in Metastatic Prostate Cancer Moves on to Phase II

PSA Levels and Outcomes in High-Risk Prostate Cancer Treated With ADT and Radiotherapy

Steroid Switch in Metastatic Prostate Cancer: Outcomes of PSA Responders Versus Nonresponders

Comparison of Outcomes With Various Treatments of Localized Prostate Cancer

Use of Apalutamide in Men With Lower-Risk Prostate Cancer on Active Surveillance

Relugolix Receives FDA Approval for Advanced Prostate Cancer

11C-Choline PET/CT and Stereotactic Ablative Radiotherapy in Prostate Cancer

View More

Advertisement

Published

Medical Literature

Artificial Intelligence and the Detection and Grading of Prostate Cancer

Adverse Reactions to Treatments of Localized Prostate Cancer: A 5-Year Study

Neural Transcription Factor: Driver for Castration-Resistant Prostate Cancer?

Risk of New Persistent Opioid Use After Minor Urologic Procedures

View More

Ongoing

CE Activities

Proceedings from the First Annual Oncology Nursing Retreat

Genomic Assays in the “Real” Oncology World: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers

Nursing Management of Treatment-Related Side Effects in Metastatic Prostate Cancer

Addressing Current Questions and Controversies in the Management of Prostate Cancer

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

City of Hope

Dana-Farber Cancer Institute

View More

Resources

For Your Patients

NCCN Guidelines for Patients®: Prostate Cancer

National Alliance of State Prostate Cancer Coalitions (NASPCC)

Prostate Conditions Education Council (PCEC)

Cancer.Net

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.